Global 3D Medical Imaging Devices Market

Diagnostic imaging equipment allows physicians to view the inside of the human body to help them find any indications of a health condition. The main types of diagnostic imaging equipment are x-ray systems devices and equipment, ultrasound systems devices and equipment, computed tomography (CT) scanners devices and equipment, magnetic resonance imaging systems devices and equipment, cardiovascular monitoring, diagnostic devices and equipment, and nuclear imaging devices, and equipment. Nuclear imaging device and equipment uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in the body and converts them into an image. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The diagnostic imaging equipment market research report is one of a series of new reports from The Business Research Company that provides diagnostic imaging equipment market statistics, including diagnostic imaging equipment industry global market size, regional shares, competitors with a diagnostic imaging equipment market share, detailed diagnostic imaging equipment market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic imaging equipment industry. This diagnostic imaging equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global diagnostic imaging equipment market grew from $48.71 billion in 2022 to $51.08 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diagnostic imaging equipment market is expected to grow to $59.1 billion in 2027 at a CAGR of 3.7%. Portable diagnostic equipment is expected to be a fast-growing segment, and competitors are focusing on developing new and innovative portable equipment during the forecast period. Owing to their ease of use and point-of-care applications, their adoption rates are steadily increasing not only for emergency and intensive care units in hospitals, but also as a part of home care organizations. There is also a growing need for portable devices in the emergency care units for easy and quick usage, faster interventions for acute events, and better monitoring. Some of the well-known products include Samsung Electronics’ 32-SLICE CT scanner, Brain Biosciences’ CERPET portable PET scanner, Siemens Healthcare’s Mobilett mira max portable X-ray systems, and Sonosite’s MicroMaxx portable ultrasound system. Major companies in the diagnostic imaging equipment market include Siemens AG, Koninklijke Philips N.V., Fujifilm Corporation, Varian Medical Systems, General Electric Company, Elekta, Carestream Health, Inc., Exact Sciences, Hologic, Inc., and Stryker Corporation. Western Europe was the largest region in the global diagnostic imaging equipment market in 2022. North America was the second largest region in the global diagnostic imaging equipment market. Africa. was the smallest region in the global diagnostic imaging equipment market. The regions covered in the diagnostic imaging equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diagnostic imaging equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The diagnostic imaging equipment market consists of sales of breast imaging devices, brain, neuroimaging devices, 3d medical imaging devices, and other devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global diagnostic imaging equipment market is segmented - 1) By Type: X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

3D diagnostic imaging services include optical imaging of body to visualize internals of body in 3D. These services are used for diagnostic purposes. 3D Diagnostic imaging enables medical professionals to probe within your body in search of signs of a disease. The main techniques of 3D diagnostic imaging services are ultrasound, MRI, X-ray, computed tomography, others. An ultrasound is a type of imaging test that utilizes sound waves to create images of organs, tissues, and other structures within the body. The various applications include oncology, cardiology, orthopedics, and others that are used by diagnostic centers, hospitals and research centers. The 3D diagnostic imaging services market research report is one of a series of new reports from The Business Research Company that provides 3D diagnostic imaging services market statistics, including 3D diagnostic imaging services industry global market size, regional shares, competitors with a 3D diagnostic imaging services market share, detailed 3D diagnostic imaging services market segments, market trends and opportunities, and any further data you may need to thrive in the 3D diagnostic imaging services industry. This 3D diagnostic imaging services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3d diagnostic imaging services market will grow from $195.51 billion in 2022 to $207.38 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global 3d diagnostic imaging services market is expected to grow to $262.32 billion in 2027 at a CAGR of 6.1%. The demand for point-of-care testing (PoCT) has been steadily increasing over the years. The growth in demand is likely to continue and drive the market for 3D diagnostic imaging services market. This is because PoCT allows physicians and medical staff to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours. Also, the changing healthcare delivery system is aimed at delivering cost effective care at patient’s home. In most of the countries, especially developing countries, more effective care for infectious diseases is needed. PoCT technologies provide effective care with easy-to-use devices and improved analytical performance and recent improvements in the speed, usability and affordability of medical imaging with 3D integration have greatly expanded the capabilities of PoCT testing systems. These advances are greatly driving the 3D diagnostic imaging services market. The 3D diagnostic imaging services market is constrained by the shortage of qualified and skilled healthcare resources. The main reasons are the aging workforce, the complexity of the latest procedures and their reluctance towards learning the new procedures, and shrinking number of accredited training programs. According to the WHO, there will be a shortage of 18 million health workers by 2030, with the majority of this personnel coming from low- and lower-middle-income countries. The shortage of skilled workforce is expected to affect the 3D diagnostic imaging services market. Therefore, there is an urgent need to train more healthcare professionals in the latest procedures and technologies including 3D imaging to enable accurate diagnosis and treatment in the most efficient manner. Introduction of improved data storage and information sharing systems such as medical cloud technology is creating more growth opportunities for 3D diagnostic imaging. This is because medical imaging requires adequate resources to process, store, exchange and use large quantities of medical data for appropriate diagnostic and treatment decisions, and advanced cloud computing in medical imaging addresses these concerns. Cloud computing is an emerging solution for questions related to delivering complex services and data interchange over the internet. Cloud computing technology enables medical data sharing across regions, allowing more patients to obtain the medical resources they need. It allows easy retrieval of data and provides doctors with more convenient clinical image data services (clear and informative images). Medical cloud imaging has become an important field of cloud computing. In January 2020, Metropolis Healthcare, a chain of diagnostic companies, acquired a 51% stake in Shraddha Diagnostic Centre for Rs 9.36 crores ($1.27 million). This acquisition helps Metropolis Healthcare expand its geographical reach into nine cities and towns in India. Shraddha Diagnostics is a private company that primarily serves the B2B segment. Major players in the 3D diagnostic imaging services market are Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Alere Inc., Bio-Reference Laboratories, DaVita Healthcare Partners Inc., Genomic Health Inc., Myriad Genetics Inc., NeoGenomics Inc., Sonic Healthcare Limited, Spectra Laboratories, and SYNLAB International GMBH.  North America was the largest region in the 3D diagnostic imaging services market in 2022. Western Europe was the second largest region in the global 3D diagnostic imaging services market. The regions covered in the global 3D diagnostic imaging services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the 3D diagnostic imaging services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The 3D diagnostic imaging services market includes revenues earned by entities by providing PET, sonography, and mammography services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global 3D diagnostic imaging services market is segmented - 1) By Technique: Ultrasound, MRI, X-ray, Computed Tomography, Other Techniques 2) By Application: Oncology, Cardiology, Orthopedic, Other Applications 3) By End User: Diagnostic Centers, Hospitals, Research Centers

Pediatric imaging is a non-invasive, cutting-edge technology that scans children's health conditions in order to provide an effective treatment plan and anticipate a child's health risk in the earliest stages of life in order to prevent medical issues in the adolescent period. The main modalities of paediatric imaging are ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), x-ray, and others. Ultrasound is used to view and obtain information about internal body parts. Ultrasound is an imaging technique commonly used in medical science that uses sound waves to form images of internal organs for diagnosis. The different applications include orthopedics, gastroenterology, cardiology, oncology, neurology, and others that are used in hospitals, diagnostic centers, and other end-users. The paediatric imaging market research report is one of a series of new reports from The Business Research Company that provides paediatric imaging market statistics, including paediatric imaging industry global market size, regional shares, competitors with paediatric imaging market share, detailed paediatric imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the paediatric imaging industry. This pediatric imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pediatric imaging market size grew from $7.93 billion in 2022 to $8.79 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pediatric imaging market size is expected to grow to $12.38 billion in 2027 at a CAGR of 8.9%. The rise in the number of pediatric ailments among children is expected to propel the growth of the pediatric imaging market going forward. Pediatric imaging is the scanning and diagnosis of smaller age group patients by using advanced technology such as ultrasound, CT scan, X-ray, and others to predict any abnormalities in children's bodies and prepare an effective treatment plan. Imaging in pediatric nuclear medicine is used to help identify life-threatening conditions in children that are congenital, infectious, non-infectious, or both, such as cancer. For instance, according to the National Cancer Institute, a U.S. Department of Health and Human Services, in 2021 approximately 15,990 children in the age group of 0-19 years were diagnosed with cancer in the United States. Therefore, the rise in the number of pediatric ailments among children is driving the growth of the pediatric imaging market. Technological advancement is the key trend being followed by companies operating in the pediatric imaging market. Major companies operating in the pediatric imaging sector are focused on developing technologically advanced products to strengthen their market position. For instance, in May 2021, Philips Healthcare, a Netherlands-based company operating in advanced medical technology for scanning, launched Spectral CT 7500, a technologically advanced super-premium scanner working on spectral technology. Spectral technology uses multiple electromagnetic waves beyond the visible spectrum RGB (Red, Blue, and Green) that are capable of obtaining a clear organ picture for diagnosis. The Spectral CT 7500 uses spectral data for scanning to provide results in a faster manner with a more confident diagnosis. Additionally, it can be used for precision diagnosis in pediatric, bariatric, and cardiac care, oncology, emergency radiology, and others. In March 2021, Fujifilm Holdings America Corporation, a US-based company operating in imaging diagnosis, acquired Hitachi Diagnostic Imaging for $1.38 billion (179 billion yen). Through the acquisition, Fujifilm Holdings America Corporation aims to strengthen its product portfolio in the imaging diagnosis segment by providing comprehensive solutions for a wide range of clinical needs and expanding its global reach in the imaging diagnosis segment. Hitachi Diagnostic Imaging is a Japan-based firm that offers a broad range of diagnostic imaging equipment, including MRI, CT, and ultrasound for kids and adults. Major players in the pediatric imaging market are General Electric Company, Siemens Healthcare GmbH, Koninklijke Philips N.V, FUJIFILM Holdings Corporation, Toshiba Medical Systems Corporation, Agfa-Gevaert Group, Carestream Health, Canon Inc., Samsung Medison Co. Ltd., Hitachi Medical Corporation, Analogic Corporation, EsaoteSpA, Medtronic plc, Mindray Medical International Limited, EDM Imaging, CAN-med Healthcare, EOS imaging, Philips Medical Systems Technologies Ltd., KARL STORZ Group, LMT Medical Systems GmbH, Maranda Lauzon Inc., SternMed GmbH, Trivitron Healthcare Pvt Ltd., X-MOL, and Shenzhen Anke High-tech Co. Ltd. North America was the largest region in the pediatric imaging market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pediatric imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The pediatric imaging market includes revenues earned by providing services such as nuclear imaging, and cystourethrogram. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pediatric imaging market is segmented - 1) By Modality: Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), X-ray, Other Modalities 2) By Application: Orthopedics, Gastroenterology, Cardiology, Oncology, Neurology, Other Applications 3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Small animal imaging (in-vivo) refers to the advanced imaging techniques for monitoring cellular activity, pharmacological effects that have been developed, and disease progression in live animals. The small animal imaging (in-vivo) is used to observe, define, and quantify normal and pathologic processes in living animal organs and tissues non-invasively. The main components of small animal imaging (in-vivo) are micro-MRI, optical imaging, nuclear imaging, and other components. Micro-MRI refers to a non-invasive technique that produces detailed 3-dimensional (3D) images of tissues without the use of harmful radiation. The various applications include monitoring treatment response, biodistribution, determining drug/target engagement, cancer cell detection, biomarkers, longitudinal studies, and epigenetics which are used in veterinary clinics, veterinary hospitals, and veterinary institutes and research centers. The small animal imaging(in-vivo)market research report is one of a series of new reports from The Business Research Company that provides small animal imaging(in-vivo)market statistics, including small animal imaging(in-vivo)industry global market size, regional shares, competitors with a small animal imaging(in-vivo)market share, detailed small animal imaging(in-vivo)market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging(in-vivo)industry. This small animal imaging(in-vivo)market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global small animal imaging (in-vivo) market size grew from $2.28 billion in 2022 to $2.54 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small animal imaging (in-vivo) market size is expected to grow to $3.8 billion in 2027 at a CAGR of 10.6%. Growing expenditure for the healthcare sector is expected to propel the growth of the small animal imaging (in-vivo) market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure and increasing healthcare awareness, encourage the concept of self-care management where PET equipment is used in techniques such as small animal imaging. For instance, according to data released by the Organisation for Economic Co-operation and Development, a France-based intergovernmental economic organization, in 2020 health spending as a share of GDP jumped to 9.7% across OECD countries, up from 8.8% in 2019. A group of 17 OECD countries suggests that health spending continued to grow strongly in 2021 by around 6%. Therefore, growing expenditure for the healthcare sector is driving the growth of the small animal imaging (in-vivo) market. Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position. For instance, in April 2022, PerkinElmer, Inc., a US-based company engaged in business areas such as diagnostics, life science research, and imaging, launched the Vega imaging system, an automated advanced technology ultrasound platform. The automated technology involves the use of two automated transducers, resulting in easy-to-use technology and generating more consistent results to visualize the pathophysiology of the disease. In August 2021, Rigaku Corporation, a Japan-based global manufacturer and distributor of scientific and industrial instrumentation primarily in X-ray and imaging technologies, acquired MILabs B.V. for an undisclosed amount. With this acquisition, Rigaku enlarged its global life sciences modality business by merging its original X-ray imaging business with MILabs' multi-modality businesses for animals, which included PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography) equipment. MILabs B.V. is a Netherland-based company engaged in the development and manufacturing of molecular preclinical imaging systems such as SPECT, PET, CT, and optical imaging systems operating in small animal imaging(in-vivo). Major players in the market are Bruker, PerkinElmer, Miltenyi Biotec, Aspect Imaging Ltd., Mediso Ltd., LI-COR Biosciences, Life Technologies Corporation, Trifoil Imaging, Promega Corporation, New England Biolabs, MR Solutions Ltd., General Electric, Sofie Biosciences Inc., Biospace Lab, and Agilent Technologies Inc. North America was the largest region in the small animal imaging (in-vivo) market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in small animal imaging (in-vivo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the small animal imaging (in-vivo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The small animal imaging (in-vivo) market includes revenues earned byPET, X-ray CT, MRI, and SPECT scanners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global small animal imaging in vivo market is segmented - 1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components 2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics 3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Nuclear imaging devices and equipment are used in the diagnosis of diseases by using small amounts of radioactive substances in the patients and are used in a wide range of medical applications including cardiology, obstetrics/gynecology, vascular, urology, and other medical applications. The main product types in the nuclear imaging devices and equipment are SPECT systems, PET systems, and planar scintigraphy. The SPECT scan is used to capture the images and create 3D scanning. These are used for various applications such as oncology, cardiology, neurology, other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology) that are used in hospitals, imaging centres, academic & research institutes, other end users (pharmaceutical/biotechnology companies and CROs). The nuclear imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides nuclear imaging devices and equipment market statistics, including nuclear imaging devices and equipment industry global market size, regional shares, competitors with a nuclear imaging devices and equipment market share, detailed nuclear imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear imaging devices and equipment industry. This nuclear imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nuclear imaging devices and equipment market size will grow from $4.02 billion in 2022 to $4.22 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nuclear imaging devices and equipment market size is expected to grow from $4.99 billion in 2027 at a CAGR of 4.3%. The nuclear imaging devices and equipment market is being driven by increasing incidences and prevalence of diseases such as cancer, heart disease, gastrointestinal, endocrine, and neurological disorders. Such diseases are diagnosed in relatively early stages by nuclear imaging equipment as compared to other equipment. For instance, according to the American Cancer Society 2020, in the United States, 1.8 million new cancer cases are diagnosed and 606,520 cancer deaths in the United States, many of which have been diagnosed by nuclear imaging devices and equipment. The nuclear imaging devices and equipment market is being restrained by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC requires nuclear imaging equipment licensees to use and store radioactive materials to protect workers and common people by removing unwanted exposure, which has resulted in a relatively less number of nuclear imaging equipment being manufactured. Companies in the nuclear imaging devices and equipment market are using hybrid imaging technologies such as positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI) for nuclear medical imaging. These hybrid systems provide precise images with better resolution and both morphological and physiological information in just one instance of testing. For instance, a SPECT/CT system for skeletal evaluation offers accurate localization and improves the specificity of information provided by CT. The Nuclear Regulatory Commission (NRC), USA regulates the manufacture and use of radioactive materials in nuclear imaging devices, as well as radiation therapy and research. It has agreements with 37 US states which allows them to regulate the use of certain radioactive materials by giving licenses to hospitals, clinics, and medical centres. The US-based Food and Drug Administration (FDA) also regulates products and procedures that are radiation-emitting. It reviews the safety and use of radiopharmaceuticals and machines like x-rays, which produce radiation but do not make or use radioactive material. In April 2020, TTG Imaging Solutions, LLC., a company operating in nuclear medicine equipment based in the United States acquired Nuclear Imaging Services and Molecular Imaging Specialists for an undisclosed amount. With this acquisition, The company wants to expand its portfolio in diagnostics imaging. Nuclear Imaging Services is a company operating in nuclear imaging based in texas and Molecular Imaging Specialists, a company operating in nuclear imaging devices and equipment based in the United States. Major players in the market are Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., SurgicEye GmbH, Siemens Healthineers, GE Healthcare, Mediso Medical Imaging Systems Ltd., Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, and Philips Healthcare. Western Europe was the largest region in nuclear imaging devices and equipment market in 2022. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nuclear imaging devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The nuclear imaging devices and equipment market consist of sales of SPECT (single-photon emission computed tomography) systems, hybrid PET systems, and planar scintigraphy imaging systems. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nuclear imaging devices and equipment market is segmented - 1) By product type: SPECT systems, PET systems, Planar Scintigraphy, 2) By application: Oncology, Cardiology, Neurology, Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology) 3) By end user: Hospitals, Imaging Centers, Academic & Research Institutes, Other End Users (Pharmaceutical/Biotechnology Companies and CROs)

Dental diagnostic imaging devices and equipment create a visual representation of the inner tooth body for clinical analysis. These devices are used for better analysis of dental problems such as tooth decay, tooth erosion, and gum disease. The main methods in dental diagnostic imaging devices and equipment are intraoral imaging and extraoral imaging. Intraoral imaging refers to the intraoral cameras that are used to provide accurate images of the teeth. The various technologies are X-Ray Systems, dental cone beam computed tomography, magnetic resonance imaging, and others. These are used in hospitals, dental clinics, forensic labs, and others. The dental diagnostic imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides dental diagnostic imaging devices and equipment market statistics, including dental diagnostic imaging devices and equipment industry global market size, regional shares, competitors with a dental diagnostic imaging devices and equipment market share, detailed dental diagnostic imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dental diagnostic imaging devices and equipment industry. This dental diagnostic imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dental diagnostic imaging devices and equipment market size will grow from $2.41 billion in 2022 to $2.72 billion in 2023 at a compound annual growth rate (CAGR) of 13.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental diagnostic imaging devices and equipment market size is expected to grow to $4.36 billion in 2027 at a CAGR of 12.5%. The growing awareness of dental health care has led to demand for a proper healthcare system with upgraded devices. The dental diagnostic imaging devices help to meet the oral healthcare demands of people and will drive market growth. These imaging devices help to reduce shorten the recovery time for a patient and also result in less pain when compared to earlier methods of diagnosing dental problems. According to Adults Oral Health & Well-being Survey, 85% of Americans believe that oral health is extremely important among which only 15% were satisfied with their current oral health. This indicates that people look for better dental care now and are aware of the importance of oral healthcare. The lack of consumer awareness on the available dental diagnostic imaging devices in many developing economies is restraining the dental diagnostic imaging market growth. People in many developing countries tend to neglect dental problems due to a lack of awareness. This attitude affects the health and also the growth of the dental diagnostic imaging device market as the use and procurement of these devices are affected negatively. For example, WHO has provided technical and financial support to the Ministry of Public Health and Education is conducting a series of workshops and campaigns on oral health for schoolteachers in Kabul city. These workshops aim to raise awareness of oral health and prevention of negligence towards dental problems. The need for precise diagnostic tools has given rise to innovation in dental imaging technology such as cone beam computed tomography (CBCT) and magnetic resonance imaging and others. These new techniques have helped in a better examination of complex facial structures and early diagnosis of dental diseases. For example, the All-India Institute of Medical Sciences (AIIMS) started the use of a Cone Beam CT (CBCT) scan facility that would help dental surgeons in increasing the efficiency of their dental surgeries. These devices provide a 3D image of the patient's jaw to get precise knowledge of the problem before the surgery is performed and help in safe and better treatment outcomes. Various government reforms and organizations are currently focusing on dental care safety and aim to reduce oral health care problems. For example, FDA's Center for Devices and radiological health is responsible for regulating firms that manufacture, repackage or import medical devices sold in the United States. Also, CDRH regulates medical devices such as radiation-emitting electronic products such as lasers, x-ray systems, and ultrasound equipment. Major players in the dental diagnostic imaging devices and equipment market are Carestream Health Inc., Fujifilm Holdings Corporation, Hitachi Medical Corporation, Siemens Healthcare, GE Healthcare, Philips Healthcare, Hologic Inc., Canon, Shimadzu Corporation, and Toshiba Medical Systems Corporation. Asia-Pacific was the largest region in the global dental diagnostic imaging devices and equipment market in 2022. Western Europe was the second-largest region in global dental diagnostic imaging devices and equipment market. The regions covered in the dental diagnostic imaging devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental diagnostic imaging devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. Dental diagnostic imaging devices and equipment consists of sales of Extraoral Imaging Systems, (Panoramic Systems, Panoramic & Cephalometric Systems, 3d CBCT Systems) And Intraoral Imaging Systems (Intraoral X-Ray Systems, Intraoral Sensors, and Intraoral PSP Systems) for dental diagnostic imaging that are used for diagnosis of dental diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global dental diagnostic imaging devices and equipment market is segmented - 1) By Method: Intraoral Imaging, Extraoral Imaging 2) By End Users: Hospitals, Dental Clinics, Forensic Labs, Other End Users 3) By Technology: X-Ray Systems, Dental Cone Beam Computed Tomography, Magnetic Resonance Imaging, Other Technologies

Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The main imaging types of brain and neuroimaging devices are functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is a type of imaging technique that measures the metabolic activity of the cells of body tissues using radioactive substances. The various applications of brain and neuroimaging devices are Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and other applications that are used in hospitals, diagnostic centers, and ambulatory surgical centers. The brain and neuroimaging devices market research report is one of a series of new reports from The Business Research Company that provides brain and neuroimaging devices market statistics, including brain and neuroimaging devices industry global market size, regional shares, competitors with a brain and neuroimaging devices market share, detailed brain and neuroimaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain and neuroimaging devices industry. This brain and neuroimaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global brain and neuroimaging devices market size will grow from $35.49 billion in 2022 to $37.53 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The brain and neuroimaging devices market size is expected to grow from $47.15 billion in 2027 at a CAGR of 5.9%. An increase in the incidence of neurological disorders is expected to drive the market. According to a report by the European Academy of Neurology, 1 in 3 people in 2022 are affected by a neurological disease and the number of deaths due to neurological disorders increased by almost 40% in the last 30 years. Brain and neuroimaging devices are used to diagnose neurological disorders increasing the survival rate and management of the disease. This increasing incidence rate is expected to drive the brain and neuroimaging devices market. The high cost of imaging devices is anticipated to hamper the market for brain and neuroimaging devices. Neurological and cognitive psychology research and design brain-computer interfaces require high-end machines such as Electroencephalography (EEG), Positron Emission Tomography (PET), Functional Magnetic Resonance Imaging (fMRI) among others. These are high-cost devices, for instance, the new 64-slice CT scanners range between $500,000 and $700,000, cost of a PETCT scanner ranges from $225,000 to $750,000, which is not affordable for all hospitals and labs, mainly in developing countries. Thus, the high cost of imaging devices hampers the buying capacity of hospitals and diagnostic labs, hampering the brain and neuroimaging devices market. Companies and researchers are focusing on developing portable brain scanners that are expected to revolutionize brain imaging by lowering the cost of devices, making them affordable and accessible to all. EMVision Medical Devices and researchers at Queensland University have developed a portable brain scanner technology that enables brain scanning to be performed at almost any location. Researchers at University College London have developed a portable MEG brain scanner that is lightweight, worn like just a helmet but can measure brain activity even as people make natural movements, providing improved imaging opportunities for patients with disorders that cause unprompted body movements, such as epilepsy. Major players in the brain and neuroimaging devices market are GE, Siemens, Philips, Canon, Hitachi Medical Systems, Medtronic PLC., EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., and Elekta. Western Europe was the largest region in the brain and neuroimaging devices market in 2022. North America was the second largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the global brain and neuroimaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the brain and neuroimaging devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales along the supply chain or as part of other products. The global brain and neuroimaging devices market is segmented - 1) By Imaging Type: Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Other Imaging Types 2) By End-user: Hospitals, Diagnostic Centres, Ambulatory Surgical Centres 3) By Application: Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Other Applications

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices